A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.

"Declarations Ethics approval and consent to participateThis retrospective study was approved by the Ethics Committee of Qilu Hospital of Shandong University (ethical approval number KYLL-2018(KS)-226). All subjects agreed to participate in this study. Informed consent has been obtained. Consent for publicationInformed consent was obtained from all subjects and/or their legal guardian(s). Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the National Nature Science Foundation (Grant no. 82200915), the Natural Science Foundation of Shandong Province (Grant no. ZR202111100201 and ZR2021MH041) and the Fundamental Research Funds for the Central Universities (Grant no. 2022JC024)."